RMIT sensor tech supports world-first sleep disorder trial

A world-first sleep disorder diagnosis and monitoring trial will be conducted using invisible sensor technology developed at RMIT University.

The trial is part of a new partnership between Melbourne-based research and technology company Sleeptite, RMIT and Flinders University.

Researchers will test Sleeptite’s non-invasive sensor monitoring technology, REMi, and investigate its capability as a validation tool for sleep disorders.

REMi is the result of an Australian Government Cooperative Research Centres – Project (CRC-P) grant, which saw fundamental research taken from RMIT labs and translated into a commercial outcome.

Launched in March, the technology is designed to non-intrusively monitor aged care residents.

Sensors on the surface of a mattress provide real-time insights into residents’ position, posture and sleep health status.

Sleeptite CEO Cameron van den Dungen said the new research harnessed REMi’s potential to provide sleep diagnostic information outside of an aged care setting.

“With a recent report from the Sleep Health Foundation and Deloitte showing 1 in 10 Australians suffer from a sleep disorder, at a national economic cost of $14.4 billion, there has never been a greater need for research in this space,” van den Dungen said.

“I am so excited to see further scientific research show how the Sleeptite REMi platform can be used as a sleep diagnostic tool to determine sleep disorders such as sleep apnoea.”

The technology will be put to the test by experts from the Flinders Health and Medical Research Institute Sleep Health team at Flinders University in collaboration with the Functional Materials and Microsystems Research Group at RMIT.

A graphic of a bed with sensors sending data to a mobile phone.

Non-invasive sensor monitoring technology developed in collaboration with RMIT.

Group co-leader, Professor Madhu Bhaskaran, said the team was excited to take their collaboration with Sleeptite into important new areas of research.

“The flexible and stretchable sensors developed at RMIT are part of what makes REMi unique – and it’s this nearable and unfeelable technology that will enable sleep studies to be carried out in far more natural settings,” Bhaskaran said.

“We look forward to discovering new avenues of partnership for this platform technology, and the opportunity to build deep collaborations to take this world-first system beyond aged care.”

Conducted at Flinders University’s Adelaide research centre, the REMi Sleep Diagnosis Evaluation Trial is expected to last six months and will include:

further sensor capability testing of the REMi sensors;
identifying key sleep-related parameters;
establishing relationships between sensor signals and sleep measurements; and,
developing an algorithm that will recognise sleep quality.

The trial will involve 30 participants and will be evaluated against polysomnography (PSG) results, which are considered the industry gold standard.

Professor Madhu Bhaskaran holding the flexible sensor technology.

Professor Madhu Bhaskaran with the flexible sensor technology to be used in the trial.

Flinders University Project Lead, Associate Professor Andrew Vakulin, said the research aimed to develop and validate sleep measurement metrics and algorithms using the REMi sensors, and to further enhance their capability to provide informative data.

“Sleep, exercise and healthy eating are essential for a healthy life, and missing out on sleep – including with an untreated sleep disorder – can have serious long and short-term health consequences,” Vakulin said.

“Our research aims to prove that the Sleeptite REMi sensors give a reliable measure of sleep quality and sleep disorders, which will ultimately lead to new apps to help consumers improve their sleep health.”

The trial was made possible due to funding received from the CRC for Alertness, Safety and Productivity.

Facts about sleep disorders and sleep health

1 in 10 Australians have a sleep disorder that can substantially affect their wellbeing, safety and productivity
In the last financial year (2019-20) poor sleep cost the Australian economy $14.4 billion, equating to 0.73% of Australian GDP
Less than 7% of these costs are for sleep disorder treatments
Non-financial costs of the loss of wellbeing totalled an additional $36.6 billion
These costs were distributed across the three major sleep disorders – obstructive sleep apnoea, insomnia and restless legs syndrome

Source: Sleep Health Foundation

Story: Gosia Kaszubska

Health

Technology

29 June 2021

Return to RMIT News

Health

Technology

29 June 2021

Research
Nano & Microtechnology
Engineering
Advanced Materials
Science and technology
Industry

Engage

Related News

Making muscles, building brains: inside the mind-blowing world of biofabrication

In a research lab at a Melbourne hospital, work is underway to turn biomedical science fiction into reality.

Sonic advance: How sound waves could help regrow bones

Researchers have used sound waves to turn stem cells into bone cells, in a tissue engineering advance that could one day help patients regrow bone lost to cancer or degenerative disease.

Early detection tech and the battle to change the story on ovarian cancer

Driven by a promise to help women win the battle against ovarian cancer, Dr Cesar Sanchez Huertas is developing new medical technologies to detect the deadly disease in its earliest stages.

The future of health and justice is already here

The Deputy Director of RMIT University’s Health Transformation Lab, Nithya Solomon, will address this week’s Newkind social justice conference, explaining how the future of healthcare has already arrived.

Acknowledgement of Country

RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business - Artwork 'Luwaytini' by Mark Cleaver, Palawa.

More information

RMIT sensor tech supports world-first sleep disorder trial